Is Intercept Pharmaceuticals Inc (ICPT) A Good Stock To Buy?
“The end to the U.S. Government shutdown, reports of progress on China-U.S. trade talks, and the Federal Reserve’s confirmation that it did not......(read more)
Posts Tagged ‘NASDAQ:ICPT’
Here’s What Hedge Funds Think About Intercept Pharmaceuticals Inc (ICPT)
While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil......(read more)
Hedge Funds Are Betting On Intercept Pharmaceuticals Inc (ICPT)
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue......(read more)
Intercept Pharmaceuticals Inc (ICPT): Are Hedge Funds Right About This Stock?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They......(read more)
Investors Are Buzzing About These 5 Morning Movers
In contrast to yesterday’s action, the major indexes are all green today, with crude futures leading the way, up by 5%. Among the stocks generating......(read more)
Why Are These Stocks Among Today’s Losers?
This week’s roller coaster is coming to and end with a bang, as U.S. stocks are deep in the red territory and the Dow is down by triple digits.......(read more)
Why Are These Five Stocks Surging on Tuesday?
Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while,......(read more)
Is Intercept Pharmaceuticals Inc (ICPT) A Good Stock To Buy?
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment......(read more)
These Five Biotech Stocks Ranked Among This UK-based Fund’s Favorites
Cheyne Capital is one of the few non-U.S firms that we track in our database. Managed by its founders, Jonathan Lourie and Stuart Fiertz, Cheyne employs......(read more)
Esperion Therapeutics Inc (ESPR), Intercept Pharmaceuticals Inc (ICPT): Visium and OrbiMed’s Recent Activity in Biotech
Stocks in the biotechnology industry have been very active as of late, with companies’ shares registering significant gains. The industry jumped......(read more)
Healthcare Hedge Fund Orbimed’s Top Picks and New Move
According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay‘s Orbimed Advisors has slashed its stake......(read more)
Applied Genetic Technologies Corp (AGTC): Steve Cohen Starts New Stake With 5.8% of The Company’s Outstanding Stock
Steve Cohen’s Point72 Asset Management disclosed today a new position in Applied Genetic Technologies Corp (NASDAQ:AGTC). The funds affiliated with......(read more)
Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen Idec Inc (BIIB): Orbimed Advisors Top Stocks in Q2
Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission. For the second quarter of 2014......(read more)
Orbimed Advisors Further Cuts Exposure To Intercept Pharmaceuticals Inc. (ICPT)
Orbimed Advisors, led by Samuel Isaly, has disclosed cutting its position in Intercept Pharmaceuticals Inc. (NASDAQ:ICPT). According to the filing, Orbimed......(read more)
Intercept Pharmaceuticals Inc. (ICPT)’s Positive Liver Cure Overshadows Dismal Second Quarter Results
Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) continues to soar in the market after the release of positive clinical data, which showed its drug for a......(read more)
NASH a Big Opportunity For Gilead Sciences, Inc. (GILD)
After being a dominant player in the hepatitis C market with its drug Sovaldi, Gilead Sciences, Inc. (NASDAQ:GILD) is now eyeing to monetize from the......(read more)
Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks
Small-cap picks from individual funds might provide investors with attractive investment options. In this article we will look into Andreas Halvorsen’......(read more)
Orbimed Advisors Cuts Stake In Intercept Pharmaceuticals Inc (ICPT)
Orbimed Advisors is limiting exposure to Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after selling approximately 81,305 shares in one transaction at......(read more)
Second Wave of Moves from SAC Capital
In another set of filing with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have revealed a number of changes......(read more)
Visium Asset Management Ups Stake in Skyrocketing Intercept Pharmaceuticals Inc (ICPT)
Jacob Gottlieb‘s Visium Asset Management has increased its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), according to an amended filing......(read more)
Steve Cohen, SAC Capital Reveal 5.3% Stake in Intercept Pharmaceuticals
Steve Cohen‘s SAC Capital has just revealed a 5.3% stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a new filing with the SEC indicates.......(read more)
Samuel Isaly’s Orbimed Advisors Sells Some Intercept Pharmaceuticals Stock at $62.50/Share
Orbimed Advisors, Intercept Pharmaceuticals: Samuel Isaly and his hedge fund, Orbimed Advisors, is focused on healthcare stocks. They recently reported......(read more)
Orbimed Downgrades its Position in Intercept Pharmaceuticals
Orbimed Advisors, Intercept Pharmaceuticals: In a recent SEC filing, Samuel Isaly and his hedge fund, Orbimed Advisors, reported decreasing their holding......(read more)
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
Should Pacira Pharmaceuticals Inc (NASDAQ:PCRX) investors track the following data? To the average investor, there are many methods market participants......(read more)
What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)
To the average investor, there are tons of methods market participants can use to track publicly traded companies. Two of the most useful are hedge fund......(read more)
This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)
Is it smart to be bullish on Neurocrine Biosciences, Inc. (NASDAQ:NBIX)? In the financial world, there are dozens of indicators investors can use to......(read more)
Hedge Funds Are Buying Impax Laboratories Inc (IPXL)
Is Impax Laboratories Inc (NASDAQ:IPXL) a good investment? At the moment, there are tons of indicators shareholders can use to analyze publicly traded......(read more)
Hedge Funds Aren’t Crazy About Rigel Pharmaceuticals, Inc. (RIGL) Anymore
Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) a good investment? In the eyes of many investors, hedge funds are seen as useless, outdated investment tools......(read more)
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are......(read more)
Nektar Therapeutics (NKTR), Stemline Therapeutics Inc (STML): Humongous Health-Care Stocks This Week
While the market jittered this week over what the Federal Reserve will do next, some stocks didn’t flinch. The fortunate investors were those who......(read more)
Hedge Funds Are Buying Endocyte, Inc. (ECYT)
Is Endocyte, Inc. (NASDAQ:ECYT) a marvelous investment today? The best stock pickers are in a bullish mood. The number of long hedge fund positions inched......(read more)
Hedge Funds Are Betting On Kythera Biopharmaceuticals Inc (KYTH)
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) was in 10 hedge funds’ portfolio at the end of March. KYTH investors should be aware of an increase......(read more)
Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)
Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood. The number of long hedge fund positions......(read more)
Neurocrine Biosciences, Inc. (NBIX): Are Hedge Funds Right About This Stock?
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds’ portfolio at the end of the first quarter of 2013. NBIX has experienced an increase......(read more)
Hedge Funds Are Betting On Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors should pay attention to an increase in hedge fund interest in recent months. According to most shareholders......(read more)
Hedge Funds Are Buying Aegerion Pharmaceuticals, Inc. (AEGR)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds’ portfolio at the end of the fourth quarter of 2012. AEGR has seen an increase......(read more)
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?: Impax Laboratories Inc (IPXL), Pacira Pharmaceuticals Inc (PCRX)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds’ portfolio at the end of December. AEGR has experienced an increase in enthusiasm......(read more)
Endocyte, Inc. (NASDAQ:ECYT), Kythera Biopharmaceuticals Inc (NASDAQ:KYTH): Should You Avoid Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)?
Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) a safe stock to buy now? Prominent investors are in a bearish mood. The number of long hedge fund bets dropped......(read more)
